1 Sleep Apnea Some people take tirzepatide to help improve sleep apnea by supporting weight loss
This approach leads to improved glycemic control and substantial weight loss, with clinical trials demonstrating HbA1c reductions of 1.9% to 2.4% and mean weight loss of approximately 15-21% in the SURMOUNT-1 trial, with up to 22.5% weight loss observed in some patients at the highest doses
Statements Author contributions RO'C: Conceptualization, Writing review & editing, Writing original draft
Attenuated luteinizing hormone (LH) pulse amplitude but normal LH pulse frequency, and its relation to plasma androgens in hypogonadism of obese men
Recently completed CARMELINA and CAROLINA trials also suggested that linagliptin did not increase HF hospitalization compared to placebo or glimepiride [57, 58]
Overall risk is low, but patients should consult their doctor before starting treatment